Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

ropidoxuridine

An orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine, with radiosensitizing activity. Upon oral administration, ropidoxuridine (IPdR) is efficiently converted to idoxuridine (IUdR) by a hepatic aldehyde oxidase. In turn, IUdR is incorporated into DNA during replication, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. Compared to IUdR, ropidoxuridine is associated with a lower toxicity profile and improved anti-tumor activity.
Synonym:IPdR
Chemical structure:2(1H)-pyrimidinone, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-iodo-
5-iodo-2-pyrimidinone 2' deoxyribonucleoside
5-iodo-2-pyrimidinone-2'-deoxyribose
NSC code:726188
Search NCI's Drug Dictionary